| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.00042 | 1 |